Provisions for breakage and expiry

Cost of return on account of breakage and expiries are
estimated on the basis of past experience. Provision is
made in respect of cost for breakage and expiries in the
year of sale of goods.

Contingencies

A disclosure for contingent liability is made when there is
a possible obligation or a present obligation that may, but
probably will not, require an outflow of resources. Where
there is a possible obligation or a present obligation and
the likelihood of outflow of resources is remote, no
provision or disclosure is made.

q) Research and development

Expenditure on research activities, undertaken with the
prospect of gaining new scientific or technical knowledge
and understanding, is recognised in the Statement of
Profit and Loss as and when incurred.

The development activities undertaken by the company
are subject to technical, regulatory and other
uncertainties, such that, in the opinion of management,
the criteria for capitalization are not met prior to
obtaining in marketing approval by the regulatory
authorities in markets. Internal development costs that do
not meet these criteria are therefore expensed as and
when incurred.

r) Earnings per share

Basic earnings per share is calculated by dividing the
profit attributable to owners of the Company by the
weighted average number of equity shares outstanding
during the financial year. The weighted average number
of equity shares outstanding during the period and for all
periods presented is adjusted for events, such as bonus
shares, other than the conversion of potential equity
shares that have changed the number of equity shares
outstanding without a corresponding change in resources
For the purpose of calculating diluted earnings per share,
diluted earnings per share adjusts the figures used in the
determination of basic earnings per share to take into
account the after income tax effect of interest and other
financing costs associated with dilutive potential equity
shares, and the weighted average number of additional
equity shares that would have been outstanding
assuming the conversion of all dilutive potential equity
shares.

s) Cash and Cash Equivalents

Cash comprises cash on hand and demand deposits with
banks. Cash equivalents are short term (with an original
maturity of three months or less from the date of
acquisition), highly liquid investments that are readily
convertible into known amounts of cash and which are
subject to an insignificant risk of changes in value.

(b) Terms / rights attached to equity shares

The company has a single class of equity shares having a
par value of Rs. 10/- per share. Accordingly, all equity
shares rank equally with regard to dividends and share in
the company's residual assets. The equity shares are

entitiled to received dividend as declared from time to
time. The votings rights of an equity shareholder ona poll
(not on show of hands) are in proportion to its share of
the paid - up equity capital of the company. Voting rights
cannot be excercised in respect of shares on which any

call or other sums presently payable have not been paid.
Failure to pay any amount called up on shares may lead
to forfeiture of the shares. On winding up of the
company, the holders of equity shares will be entitled to
received the residual assets of the company, remaning

after distribution of all preferential amounts in proportion
to the number of equity shares held

Fair Value Hierarchy

The fair values of the financial assets and liabilities are included at the amount that would be received to sell an asset or paid to
transfer a liability inan orderly transaction between market participants at the measurement date.

This section explains the judgements and estimates made in determining the fair values of the financial instruments that are (a)
recognised and measured at fair value and (b) measured at amortised cost and for which fair values are disclosed in the financial
statements. To provide an indication about the reliability of the inputs used in determining fair value, the Company has classified its
financial instruments into the three levels prescribed under the accounting standard. An explanation of each level follows
underneath the table.

Level 1: Level 1 hierarchy includes financial instruments measured using quoted prices. The Company doesn't have investment in
equity instruments that have quoted price.

Level 2: The fair value of financial instruments that are not traded in an active market is determined using valuation techniques
which maximise the use of observable market data and rely as little as possible on entity-specific estimates. If all significant inputs
required to fair value an instrument are observable, the instrument is included in level 2. Instruments in the level 2 category for the
Company include forward exchange contract derivatives

Level 3: If one or more of the significant inputs is not based on observable market data, the instrument is included in this level.
Instruments in level 3 category for the Company include unquoted equity shares.

Fair Value for Assets Measured at Amortised Cost

During the years mentioned above, there have been no transfers amongst the levels of hierarchy.

The carrying amounts of trade receivables, cash and cash equivalents, and other bank balances, current loans, other current
financial assets, current borrowings, trade payables and other financial liabilities are considered to be approximately equal to the
fair value.

Valuation Process

The Company evaluates the fair value of financial assets and financial liabilities on periodic basis using the best and most relevant
data available.

Also, the Company internally evaluates the valuation process and obtains independent price validation for certain instruments
wherever necessary.

Note - 37

Financial Risk Management

The Company's activities expose it to a variety of financial risk, including market risk, credit risk and liquidity risk. The company's
primary risk management focus is to minimize potential adverse effect of market risk on its financial performance. The Comapany's
risk management assessment, policies and process are established to identify and analyze the risk faced by the comapny, to set
appropriate risk limits and controls, and to monitor such risks and compliance with the same. Risk assessment and management
policies and process are reviewed regularly to reflect changes in market conditions and the comapany's activities. The Board of
Directors and the Audit Committee is responsible for overseeing the company's risk assessment and management policies and
processes

Financial risk management

1 Credit risk

2 Liquidity risk and

3 Market risk

Credit risk

Credit risk

Credit risk is the risk of financial loss to the company if a customer or counter party to a financial instrument fails to meet its
contractual obligations, and arises pricipally from the company's receivables from customers. Credit risk is managed through credit
approvals, establishing credit limits and continously monitoring the creditworthiness of customers to which the company grants
credit terms in normal course of business. The company establishes an allowance for doubtful debts and impairment thats
represents its estimate of incurred losses in respect of trade and other receivables and investments

Trade and other receivable

The company's exposure to credit risk is influenced mainly by the individual charracteristic of each customer. The demographics of
the customer, including the default risk of the industry and country in which the customer operates, also has an influence on credit
risk assessment. Credit risk is managed through credit approvals, establishing credit limits and continuously monitoring the
creditworthiness of customers to which the company grants credit terms in the normal course of business.

Expected credit loss assessment

Exposure to customers outstanding at the end of each reporting period are reviewed by the company to determine and expected
credit losses. Historical trends of impairment of trade receivables do not reflect any significant credit losses. Given that the macro
economic indicators affecting customers of the company have not undergone any substantial change, the company expects the
historical trend of minimal credit losses to continue. Further, management believes that the unimpaired amounts that are past due
by more than 30 days are still collectible in full, based on historical payment behaviour and extension analysis of customer credit
risk. The impairment loss at 31 March, 2025 related to several customers that have defaulted on their payments to the comapny
and are not expected to be able to pay their outstanding balances, mainly due to economic circustances.

Cash and cash equivalents

As on 31 March, 2025 the company held cash and cash eqivalents and other bank balances with credit worthy banks and financial
institutions of . 64,90.41 Lacs (31 March, 2025 Rs. 22.97 Lacs ). The credit worthiness of such banks and financial institutions is
evaluted by the management on an ongoing basis and is considered to be good.

ii Liquidity risk

Liquidity risk is the risk that the company will not be able to meet its financial obligations as they become due. The company
manages its liquidity risk by ensuring, as far as possible, that it will always have sufficient liquidity to meet its liabilities when due,
under both normal and stressed conditions, without incurring unacceptable losses or risk to the company's reputation.

The Company manages its liquidity risk by regularly monitoring its rolling cash flow forecasts. The Company's operations provide a
natural liquidity of receivables against payments due to creditors. Borrowings are managed through credit facilities agreed with the
Banks, internal accruals and realisation of liquid assets. In the event of cash shortfalls, the Company approaches the lenders for a
suitable term extension

iii Market risk

Market risk is the risk of loss of future earnings, fair values or future cash flows that may result from adverse changes in market
rates and prices (such as interest rates, foreign currency exchanges rates) or in the prices of market risk - sensitive instruments as
as result of such adverse changes in market rates and prices. Market risk is attributable to all market risk - sensitive financial
instruments, all foreign currency receivables and payables and all short term and long - term debt. The Comapny is exposed to
market risk primarily related to foreign exchange rate risk, interest rate risk and the market value of its investments. Thus, the
Comapny's exposure to market risk is a function of investing and borrowing activities and revenue generating and operating
activities in foreign currencies

A Currency risk

The fluctuations in foreign currency exchanges rates may have potential impact on the profit and loss account, where any
transaction references more han one currency or where assets/laibilities are denominated in a currency other than the functional
currency of the entity

Considering the countries and economic environment in which the company operates, its operations are subject to risks arising
from fluctuations in exchange rates in those countries. The risks primarily relate to fluctuations in USD gainst the respective
functional currency of the company.

As of March 31, 2026, the Company's exposure to foreign currency risk, expressed in INR, is given in the table below. The amounts
represent only the financial assets and liabilities that are denominated in currencies other than the functional currency of the
Company.

Note - 38

Related party relationships, transaction and balances

The table provides the information about the Group's structure including Key Management Personnel and Business
Organisation controlled by Key Management Personnel or their relatives. The following table provides the total amount
of transaction that have been entered into with related parties for the relevant financial year

Note - 39

Segment reporting and Disclosure pursuant to Ind AS 115 "Revenue from Customers"

Operating segment are components of the Group whose operating results are regularly reviewed by the Chief Operating
Decision Maker [CODM] to make decisions about resources to be allocated to the segment and assess its performance
and for which discrete financial information is available. Pharmaceuticals is identified as single operating segment for
the purpose of making decision on allocation of resources and assessing its performance.

Note - 40

Events after the Reporting Period:

1. There are no significant subsequent events that would require adjustments or disclosures in the financial statements
as on the balance sheet date except Point No 2 below.

2. The proposed dividend of Rs. 0.70 per Share is recommended by the Board which is subject to the approval of
shareholders in the ensuing Annual General Meeting.

Note - 41

Figures For the previous year have been re-grouped/re-arranged wherever necessary to conform current year's
dassiftcation.

Note - 42

Dues to micro and small enterprise

The disclosure pursuant to the Micro, Small and Medium Enterprises Development Act, 2006, (MSMED Act) for dues to
micro enterprises

and small enterprises as at March 31, 2026 and March 31, 2025 is as under:

43. Provisions & Contingent Liabilities( Amount In Lacs)

Accounting Policy

Contingent liability is a possible obligation arising from past events and whose existence will be confirmed only
by the occurrence or non-occurrence of one or more uncertain future events not wholly within the control of
the entity or a present obligation that arises from past events but is not recognized because it is not probable
that an outflow of resources embodying economic benefits will be required to settle the obligation or the
amount of the obligation cannot be measured with sufficient reliability.

44. Capital Commitments

The company does not have any capital commitments as at 31th March, 2026

45. Non-cancellable Operating Leases

The Company has taken various residential/office premises/factory godowns under operating lease or leave
and license agreement with no restrictions and are renewable/ cancellable at the option of either of the
parties. There are no sub-leases. The lease payments recognised under “Rent Expenses” are:

47. Capital Management

The company's objective while managing capital are:

1. Safeguard its ability to continue as a going concern

2. Maintain an optimal mix of debt and capital to reduce overall cost of capital

3. Provide adequate returns to shareholders

(i) Leave Obligations

The leave obligations cover the Company's liability for sick and earned leave. The amount of the provision of
Rs.2,31,25,818/- (March 31, 2025 Rs. 1,97,67,963/-) is presented as non current liabilities, since the Company does
not have an unconditional right to defer settlement for any of these obligations. However, based on past
experience, the Company does not expect all employees to take the full amount of accrued leave or require
payment within the next 12 months.

(ii) Post-Employment Obligations
Gratuity

The Company provides for gratuity for employees in India as per the Payment of Gratuity Act, 1972. Employees who
are in continuous service for a period of 5 years are eligible for gratuity. The amount of gratuity payable on
retirement/ termination is the employees last drawn basic salary per month computed proportionately multiplied
for the number of years of service as per the Scheme .

(iii) Defined Contributions Plans

The Company also has certain defined contribution plans . Contributions are made to provident fund in India for
employees at the rate of 12% of basic salary as per regulations. The contributions are made to registered provident
fund administered by the government. The obligation of the Company is limited to the amount contributed and it
has no further contractual nor any constructive obligation. Amount recognized as an expense during the period
towards defined contribution plan is Rs.1,00,06,165/- (March 31, 2025 Rs.60,58,676/-).

Details of Gratuity

The amounts recognised in the balance sheet and the movements in the net defined Benefits obligation over the
year are as follows:

Risk exposure and Asset Liability Matching

Provision of a defined benefit scheme poses certain risks, some of which are detailed hereunder, as companies take
on uncertain long term obligations to make future benefit payments.

1. Liability Risks

a. Asset-liability Mismatch Risk -

Risk which arises if there is a mismatch in the duration of the assets relative to the liabilities. By matching duration
with the defined benefit liabilities, the Company is successfully able to neutralize valuation swings caused by interest
rate movements. Hence companies are encouraged to adopt asset-liability management.

b. Discount Rate Risk -

Variations in the discount rate used to compute the present value of the liabilities may seem small, but in practice
can have a significant impact on the defined benefit liabilities.

c. Future Salary Escalation and Inflation Risk -

Since price inflation and salary growth are linked economically, they are combined for disclosure purposes. Rising
salaries will often result in higher future defined benefit payments resulting in a higher present value of liabilities
especially unexpected salary increases provided at management's discretion may lead to uncertainties in estimating
this increasing risk.

2. Unfunded Plan Risk

This represents unmanaged risk and a growing liability. There is an inherent risk here that the Company may default
on paying the benefits in adverse circumstances, Funding the plan removes volatility in company's financials and
also benefit risk through return on the funds made available for the plan.

Note 51 Corporate Social Responsibility

As per Section 135 of the Companies Act, 2013, a company, meeting the applicability threshold, needs to spend at
least 2% of its average net profit for the immediately preceding three financial years on corporate social
responsibility (CSR) activities.

The areas for CSR activities are eradication of hunger and malnutrition, promoting education, art and culture,
healthcare, destitute care and rehabilitation, environment sustainability, disaster relief, COVID-19 relief and rural
development projects. A

CSR committee has been formed by the company as per the Act. The funds were primarily allocated to a corpus and
utilized through the year on these activities which are specified in Schedule VII of the Companies Act, 2013:

Note - 52

There are no Benami properties held by the Company. Also, there has been no proceedings initiated or pending
against the Company for holding any benami property under the Benami Transactions (Prohibition) Act, 1988 (45
of 1988) and rules made thereunder.

Note - 53

The Company has not traded or invested in Crypto currency or Virtual currency during the financials year.

Note - 54

There are no transactions which are recorded in the books of account which have been surrendered or disclosed as
income during the year in the tax assessments under the Income Tax Act, 1961

Note - 55

The Company has not advanced or loaned or invested (either from borrowed funds or share premium or any other
source of funds) to other person(s) or entity(ies), including foreign entities (Intermediaries) with the understanding
that the intermediary shall whether directly or indirectly lend or invest in other persons or entities identified in any
manner whatsoever by or behalf of the Company (Ultimate Beneficiaries) or provide any guarantee, security or like
on or behalf of the Ultimate Beneficiaries.

The Company has not received any funds from any person(s) or entity(ies), including foreign entities (Funding Party)

with the understanding whether directly or indirectly lend or invest in other persons or entities identified in any manner
whatsoever by or behalf of the Company (Ultimate Beneficiaries) or provide any guarantee, security or like on or behalf
of the Funding Party (Ultimate Beneficiaries) or provide any guarantee, security or like on or behalf of the Ultimate
Beneficiaries.

Note - 56

The standalone financial statements were authorised for issue in accordance with a resolution passed of the Board of
Directors in its meeting held on May 25, 2026.

Note - 57

The company does not have any charges or satisfaction which is yet to registered with ROC beyond statutory period
Note - 58

Each entity in the Group has complied with the number of layers prescribed under clause (87) of section 2 of the
Companies Act, 2013 read with Companies (Restriction on number of Layers) Rules, 2017

Note - 59

There are no approved schemes or arrangements which has been approved by the competent authorirty in terms of
section 230 to 237 of
Companies Act, 2013